drugset / Trial / NCT06270680

Carotenoids for Collision Athletes

NCT06270680

NaParallel-groupTriple-blindBasic science

Summary

This is a supplement study being conducted to find out if collision sport athletes who are exposed to repetitive head impacts while supplementing with carotenoids will have decreased pro-inflammatory blood biomarkers, increases in macular pigment optical density, improved contrast sensitivity, greater retinal nerve fiber thickness, and better overall visual quality of life scores compared to collision athletes taking a placebo.

Timeline

Start
2024-08-01
Primary completion
2024-11-22
Completion
2024-11-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject DHA Unknown 250 mg Oral
Subject EPA Unknown 50 mg Oral
Subject Lutein Other / unclassified 10 mg Oral
Subject Zeaxanthin Small molecule 2 mg Oral
Subject mesozeaxanthin Unknown 10 mg Oral